Emerging Technologies
Digital health stakeholders said that AI will be used next year to help ease administrative tasks for providers, improve clinical trial participation and increase transparency in healthcare.
The California-based company will use the funds to expand its Whole Body Twin Technology, aimed at preventing and reversing metabolic disease.
Rock Health's Digital Health at the Turn of 2024 report found retailers as providers and data interoperability are scaling innovations in the sector, with lasting trajectories.
The tech giant revealed it created an LLM optimized for diagnostic reasoning with the ability to generate a differential diagnosis or assist clinicians in coming to a diagnosis.
Execs overwhelmingly cite genAI as having the most significant impact in healthcare this year, though others provide alternative takes on the years' events.
The companies will leverage Absci's AI-enabled Integrated Drug Creation platform and the pharma giant's oncology research and development expertise.
Dr. Michael Howell, chief clinical officer at Google, discusses Med-PaLM's evolution in 2023 and recommendations for regulators developing rules for AI use in healthcare.
An automotive manufacturer in Japan has transformed its speech-to-text mobile app to an audio recognition system to help alleviate barriers in communication.
The gastrointestinal surgery-focused company will use the funds to advance its endoluminal robotics technology for minimally invasive procedures.
The partners will leverage IBM’s foundation model technologies to help identify antibodies designed to target and neutralize various disease-causing agents or cells.